发明名称 |
USE OF A PEPTIDE AS A THERAPEUTIC AGENT |
摘要 |
The present invention is directed to the use of the combination of the Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-lle-Met-Asn-Leu-Leu-Phe-Asn-lle-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-lle-NH2 and Asp-Asn-Pro-Ser-Leu-Ser-lle-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-lle-lle-Phe-Asp-Ser-Val-NH2 as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease. |
申请公布号 |
WO2009043521(A2) |
申请公布日期 |
2009.04.09 |
申请号 |
WO2008EP08104 |
申请日期 |
2008.09.09 |
申请人 |
MONDOBIOTECH LABORATORIES AG;BEVEC, DORIAN;CAVALLI, FABIO;CAVALLI, VERA;BACHER, GERALD |
发明人 |
BEVEC, DORIAN;CAVALLI, FABIO;CAVALLI, VERA;BACHER, GERALD |
分类号 |
A61K38/22;A61P3/00;A61P9/00;A61P11/00;A61P25/28;A61P31/00;A61P35/00 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|